SCHEMBL2493490

SCHEMBL2493490

Cc1ccc(C)c(S)c1S

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.39
ACHE P22303 2/20 0.38
TSHR P16473 1/20 0.38
ALDH1A1 P00352 4/20 0.33
TDP1 Q9NUW8 2/20 0.33
PSMD14 O00487 1/20 0.32
COPS5 Q92905 1/20 0.32
POLB P06746 2/20 0.32
CASP1 P29466 1/20 0.32
CYP2A6 P11509 1/20 0.32
NOS3 P29474 1/20 0.30
NOS1 P29475 1/20 0.30
NOS2 P35228 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA7 P43166 1/20 0.30
CA9 Q16790 1/20 0.30
MAPT P10636 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1402586 0.82 CYP1A2 (0.36) CYP1A2ACHETSHRPOLBCYP2A6
SCHEMBL191201 0.77
SCHEMBL19442816 0.77 ACHE (0.33) CYP1A2ACHE
SCHEMBL7649492 0.77 ALDH1A1 (0.48) CYP1A2ACHETSHRALDH1A1TDP1
SCHEMBL29367536 0.77 PSMD14 (0.35) CYP1A2PSMD14COPS5POLB
SCHEMBL330523 0.77 PSMD14 (0.35) CYP1A2PSMD14COPS5POLB
SCHEMBL18388110 0.77 CYP1A2 (0.30) CYP1A2
SCHEMBL104361 0.77 POLB (0.48) TSHRALDH1A1TDP1POLBCASP1
SCHEMBL18364490 0.76
SCHEMBL7735306 0.74 CYP1A2 (0.47) CYP1A2ACHETSHRALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188161-B1 Anaerobic cure systems for anaerobic curable compositions, and anaerobic curable compositions containing same HENKEL CORPORATION (US) 2012-05-29 US claimed
WO-2010085461-A2 NOVEL ANAEROBIC CURE SYSTEMS FOR ANAEROBIC CURABLE COMPOSITIONS, AND ANAEROBIC CURABLE COMPOSITIONS CONTAINING SAME HENKEL CORPORATION (US) 2010-07-29 WO claimed
US-20040063870-A1 Curable epoxy-based compositions LOCTITE (R&D) LTD. 2004-04-01 US claimed
EP-1047744-B1 CURABLE EPOXY-BASED COMPOSITIONS LOCTITE R & D LTD (IE) 2002-10-02 EP claimed
EP-4377373-A1 CURABLE, ONE-PART, DUAL-STAGE THIOL-ENE-EPOXY LIQUID ADHESIVES AND METHODS 3M Innovative Properties Company (US) 2024-06-05 EP disclosed
EP-3998252-B1 THIOL COMPOUNDS, SYNTHESIS METHOD THEREFOR, AND UTILIZATION OF SAID THIOL COMPOUNDS SHIKOKU CHEM (JP) 2024-04-24 EP disclosed
US-11894164-B2 Stretchable conductors 3M INNOVATIVE PROPERTIES COMPNAY (US) 2024-02-06 US disclosed
US-11884850-B2 Adhesive film including a (meth)acrylate matrix including a curable epoxy/thiol resin composition, tape, and method 3M INNOVATIVE PROPERTIES COMPANY (US) 2024-01-30 US disclosed
US-11807596-B2 Thiol compounds, synthesis method therefor, and utilization of said thiol compounds SHIKOKU CHEMICALS CORPORATION (JP) 2023-11-07 US disclosed
US-11773207-B2 Thiol compound, method for synthesizing same, and uses for said thiol compound SHIKOKU CHEMICALS CORPORATION (JP) 2023-10-03 US disclosed
US-11732135-B2 Photocurable silicone composition DOW SILICONES CORPORATION (US) 2023-08-22 US disclosed
WO-2023100828-A1 CURABLE COMPOSITION AND CURED PRODUCT THEREOF ENEOS株式会社 2023-06-08 WO disclosed
EP-1047744-A1 CURABLE EPOXY-BASED COMPOSITIONS Loctite (R & D) Limited (IE) 2000-11-02 EP disclosed
US-6025202-A PROCESS FOR DETECTING AND QUANTIFYING AN AMOUNT OF A CHEMICAL COMPOUND IN A CARRIER BY SUBJECTING SAMPLE TO RAMAN SPECTROSCOPY THE PENN STATE RESEARCH FOUNDATION (US) 2000-02-15 US disclosed
WO-1999036484-A1 CURABLE EPOXY-BASED COMPOSITIONS LOCTITE (R & D) LIMITED (IE) 1999-07-22 WO disclosed
WO-1998010289-A9 SELF-ASSEMBLED METAL COLLOID MONOLAYERS 1998-05-22 WO disclosed
WO-1998010289-A1 SELF-ASSEMBLED METAL COLLOID MONOLAYERS THE PENN STATE RESEARCH FOUNDATION (US) 1998-03-12 WO disclosed
US-5609907-A SURFACE ENHANCED RAMAN SCATTERING THE PENN STATE RESEARCH FOUNDATION (US) 1997-03-11 US disclosed
WO-1996007487-A1 METHOD OF SYNTHESISING MATERIALS HAVING CONTROLLED ELECTRONIC, MAGNETIC AND/OR OPTICAL PROPERTIES THE UNIVERSITY OF LIVERPOOL (GB) 1996-03-14 WO disclosed
EP-0565891-A1 Copolymer latex, production and use thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-10-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773207-B2 Thiol compound, method for synthesizing same, and uses for said thiol compound TST, TMT1A, CTH CYP1A2 2816/4885ACHE 1401/4885TSHR 3486/4885
US-11807596-B2 Thiol compounds, synthesis method therefor, and utilization of said thiol compounds TMT1A, CTH, SLC7A11 CYP1A2 2366/4885ACHE 2232/4885TSHR 4698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.